Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 5 months ago Source:  Radcliffe CVRM
Patients receiving maintenance haemodialysis have a cardiovascular mortality rate more than 20 times higher than the general population, and many standard preventative therapies have proven ineffective in this high-risk group. The results of a new randomised clinical trial, PISCES, suggest that daily supplementation with fish oil could offer a significant benefit, substantially reducing the rate… View more
Job title: Director, Minimally Invasive and Robotic Surgery
Personal History Dr Mick is the Director of Minimally Invasive and Robotic Surgery and Associate Professor of Cardiothoracic Surgery at Weill Cornell Medicine. Her interests are in robotically assisted cardiac surgery, percutaneous valve treatments and the team approach in cardiac disorders.1, 2 In her leisure time, she enjoys skiing, travel and music.1 Academic History Dr Mick… View more
Job title: Consultant Interventional Cardiologist and Associate Professor
Dr Robert Gerber is a Consultant Cardiologist working in East Sussex, United Kingdom, where he practices at both Conquest Hospital in Hastings and Eastbourne District General Hospital. Born and raised in the UK, Dr Gerber completed his medical education at King’s College London, where he also undertook the MB/PhD programme, distinguishing himself early in his academic and clinical career. Outside… View more
Research Area(s) / Expertise:

Expertise

Job title: Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a… View more
Job title: Professor of Interventional Medicine
Professor Patrick W. Serruys was born in Belgium in 1947. He completed his medical degree (M.D.) at the University of Leuven in 1972 and initially pursued research in muscle physiology before moving into cardiology, setting the stage for a lifelong career in interventional cardiovascular medicineProf Patrick W. Serruys is widely regarded as one of the most influential interventional cardiologists… View more
Added: 1 year ago Source:  European Renal Association
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular disease but without diabetes.1Unveiling the results today at the 61st ERA Congress, researchers presented the impressive secondary analysis from the SELECT (Semaglutide… View more